Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (2)

2017

  1. Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-β concentrations and cognition outcomes in Alzheimer's disease patients: A multicenter, randomized, controlled clinical trial

    Journal of Alzheimer's Disease, Vol. 56, Núm. 1, pp. 129-143

2009

  1. Amyloid-targeted therapeutics in Alzheimer's disease: Use of human albumin in plasma exchange as a novel approach for Aβ mobilization

    Drug News and Perspectives, Vol. 22, Núm. 6, pp. 325-339